This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&ATargeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma.

Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma.https://www.cnbc.com/2024/05/23/this-up-and-coming-cancer-treatment-could-be-a-25-billion-market-opportunity.html[Collection]